Literature DB >> 16996602

Trends of penetrating keratoplasty in the United States from 1980 to 2004.

Jason K Darlington1, Sean D Adrean, Ivan R Schwab.   

Abstract

PURPOSE: To examine the changing trends in penetrating keratoplasties (PKs) performed in the United States.
DESIGN: Retrospective review.
METHODS: Review of Eye Bank Association of America (EBAA) data on corneal tissue distribution in the United States from 1980 to 2004. Data analysis was retrospective. United States population census data were obtained and used for population-adjusted calculations. A series of Poisson regression models were calculated looking at the temporal trends over time. MAIN OUTCOME MEASURES: The estimated yearly percent change and P values were calculated using Poisson regression models.
RESULTS: The total number of corneas distributed for PKs from EBAA member eye banks have steadily increased since 1980. In 1990, the international and domestic distribution data were separated. The total number of PKs performed from EBAA-supplied tissue has continued to rise since 1990; however, the total number of PKs performed in the United States has steadily declined and when population-adjusted rates are examined, the rate of decline is more dramatic.
CONCLUSION: Although both absolute numbers and age-adjusted numbers of PKs have declined recently, the population-adjusted rates have dropped more significantly.

Mesh:

Year:  2006        PMID: 16996602     DOI: 10.1016/j.ophtha.2006.06.034

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

Review 1.  Trends in penetrating keratoplasty in the United States 1980-2005.

Authors:  Faris R Ghosheh; Federico A Cremona; Christopher J Rapuano; Elisabeth J Cohen; Brandon D Ayres; Kristin M Hammersmith; Irving M Raber; Peter R Laibson
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

Review 2.  Molecular bases of corneal endothelial dystrophies.

Authors:  Thore Schmedt; Mariana Mazzini Silva; Alireza Ziaei; Ula Jurkunas
Journal:  Exp Eye Res       Date:  2011-08-10       Impact factor: 3.467

3.  Trends in Corneal Transplantation in Keratoconus.

Authors:  Daniel Sarezky; Stephen E Orlin; Wei Pan; Brian L VanderBeek
Journal:  Cornea       Date:  2017-02       Impact factor: 2.651

4.  Changing trends in corneal graft surgery: a ten-year review.

Authors:  Ugo de Sanctis; Camilla Alovisi; Luigi Bauchiero; Guido Caramello; Gianfranco Girotto; Claudio Panico; Luisa Vinai; Federico Genzano; Antonio Amoroso; Federico Grignolo
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

Review 5.  The Human Eye Proteome Project: perspectives on an emerging proteome.

Authors:  Richard D Semba; Jan J Enghild; Vidya Venkatraman; Thomas F Dyrlund; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2013-08       Impact factor: 3.984

6.  Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy.

Authors:  Ula V Jurkunas; Maya S Bitar; Toshinari Funaki; Behrooz Azizi
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

7.  The effects of ROCK inhibitor Y-27632 on injectable spheroids of bovine corneal endothelial cells.

Authors:  Yonglong Guo; Qing Liu; Yan Yang; Xiaoling Guo; Ruiling Lian; Shanyi Li; Chan Wang; Shiqi Zhang; Jiansu Chen
Journal:  Cell Reprogram       Date:  2014-12-30       Impact factor: 1.987

8.  Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells.

Authors:  Nermin Serbecic; Imad Lahdou; Alexander Scheuerle; Romana Höftberger; Fahmy Aboul-Enein
Journal:  Mol Vis       Date:  2009-07-08       Impact factor: 2.367

9.  Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy.

Authors:  Ula V Jurkunas; Ian Rawe; Maya S Bitar; Cheng Zhu; Deshea L Harris; Kathryn Colby; Nancy C Joyce
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-31       Impact factor: 4.799

Review 10.  Fuchs endothelial cornea dystrophy: a review of the genetics behind disease development.

Authors:  Cecily E Hamill; Thore Schmedt; Ula Jurkunas
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.